ESC Premium Access

Discussant review: Assessment of REmote HEArt Rhythm Sampling using the AliveCor heart monitor to scrEen for Atrial Fibrillation.

Congress Presentation

About the speaker

Professor Christophe Leclercq

Hospital Pontchaillou of Rennes, Rennes (France)
60 presentations
10 followers

12 more presentations in this session

Clinical effects of anacetrapib in people with established vascular disease: Results of the Randomized EValuation of the Effects of Anacetrapib through Lipid-modification (HPS3/TIMI55-REVEAL) trial

Speaker: Professor M. Landray (Oxford, GB)

Thumbnail

Discussant review: Clinical effects of anacetrapib in people with established vascular disease: Results of the Randomized EValuation of the Effects of Anacetrapib through Lipid-modification (HPS3/TIMI55-REVEAL) trial

Speaker: Professor J. Chapman (Paris, FR)

Thumbnail

Panel discussion.

Thumbnail

Does intensive treat-to-target LDL-C lowering therapy using statin in patients of diabetic retinopathy reduce cardiovascular events?: the EMPATHY study

Speaker: Professor H. Itoh (Tokyo, JP)

Thumbnail

Discussant review: Does intensive treat-to-target LDL-C lowering therapy using statin in patients of diabetic retinopathy reduce cardiovascular events?: the EMPATHY study

Speaker: Professor E. Prescott (Copenhagen, DK)

Thumbnail

Access the full session

Hot Line: Late-Breaking Clinical Trials 4

Speakers: Professor C. Leclercq, Professor M. Landray, Professor J. Chapman, Professor H. Itoh, Professor E. Prescott
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations